Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: FOLFOXIRI With or Without Intensification for Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the FOLFOXIRI chemotherapy regimen with or without intensification for rectal cancer; the study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Irinotecan (Irinotecan)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: CCTU | Conditions: Rectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING